Published on 16 May 2024 on GuruFocus.com via Yahoo Finance
On May 14, 2024, Nikhil Lalwani, President & CEO of ANI Pharmaceuticals Inc (NASDAQ:ANIP), executed a sale of 16,669 shares of the company. The transaction was filed on the same day through an SEC Filing. This sale is part of a series of transactions over the past year, where the insider has sold a total of 130,208 shares.
Warning! GuruFocus has detected 5 Warning Signs with ANIP.